Drugs@FDA document
PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE Letter · ANDA 204982 SUPPL-12
Drugs@FDA document · ACTAVIS LABS FL INC · Jun 17, 2025
Key facts
| Drug name | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE |
|---|---|
| Document type | Letter |
| Application | ANDA204982 |
| Submission | SUPPL-12 |
| Company | ACTAVIS LABS FL INC |
| Document date | Jun 17, 2025 |
| FDA document | accessdata.fda.gov |
At a glance
- REMS - MODIFIED - D-N-A Document categories
- 1–9 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: